Ann: IHL commences manufacturing of skin therapeutics, page-41

I think the market reaction today is closely aligned with your thinking. Income/revenue streams are nowhere to be seen in the ST.................any income would offset getting products to clinic..............the more products the more money will be required to get these products to clinic .........market is reflecting this ST potential for now, where no new revenue is potentially going to have a negative affect down the track.

LT my view does not change..........ST, I will have tp wear it and of course build on that position while averaging down

It is this thinking that chewables, OTC products, IMO should become an income stream sooner rather than later

Just think aloud